← Leaderboards
David Seftel
Enable Biosciences Inc
$1,169,399
Attributed
$1,169,399
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $899.6K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NSF$1,169,399 · 2
By mechanism
—$1,169,399 · 2
Top collaborators
No co-investigators on record.
Grant awards (2)
SBIR Phase II: Development of an ultrasensitive, high-throughput autoantibody discovery platform using agglutination-PCR$899,627
· FY2018 · TIP · contact PI
SBIR Phase I: Development of an ultrasensitive, high-throughput autoantibody discovery platform using agglutination-PCR$269,772
· FY2016 · TIP · contact PI